Daxor Corporation (DXR) - Latest Market Data

Price & Market Data

Price: $10.50

Daily Change: +$0.45 / 4.29%

Daily Range: $10.03 - $12.22

Market Cap: $61,185,864

Daily Volume: 66,472

Performance Metrics

1 Week: -3.26%

1 Month: 11.35%

3 Months: -13.93%

6 Months: -18.98%

1 Year: 44.63%

YTD: -28.81%

About Daxor Corporation (DXR)

Understand the current valuation of Daxor Corporation (DXR). Trading at 10.50, the stock has observed a daily change of +$0.45 / 4.29%. A robust market capitalization of 61,185,864 underscores its market presence. Key performance indicators include YTD (-28.81%) and 1-year (44.63%) returns.

Details

Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.

Selected stocks

Cingulate Inc. (CING)

H2O America (HTO)

WSFS Financial Corporation (WSFS)

Merit Medical Systems, Inc. (MMSI)

World Acceptance Corporation (WRLD)